Home / R&D

Research & development

The company began its work to connect knowledge and industry, put new ideas into practice, and industrialise the production and processing of chemical, pharmaceutical and medical products.

RoshdBioZen

A xenograft bioimplant derived from bovine pericardium.

In 1401 (Solar Hijri), RBS produced a laboratory prototype of a xenograft bioimplant derived from bovine pericardium. On 1402/01/20 (Solar Hijri), it was assessed and approved as a nascent knowledge-based company by the Vice Presidency for Science, Technology and Knowledge-Based Economy.

RBS is pursuing production of RoshdBioZen as one of its strategic products.

1401

Laboratory prototype of a xenograft bioimplant derived from bovine pericardium.

1402/01/20

Assessment and approval as a nascent knowledge-based company.

1405/03/01

Allograft sales representation for dental centres in Tehran Province.

Dates above use the Solar Hijri calendar.